Quest Diagnostics Inc. vs. Freenome, Inc. Common stock
Quest Diagnostics Inc. and Freenome, Inc. Common stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| DGX | FRNM | |
|---|---|---|
| Market Cap | $25.75 billion | $1.75 billion |
| Revenue (TTM) | $11.56 billion | — |
| Net Income (TTM) | $1.11 billion | — |
DGX leads on 1 of 1 size & scale factors.
Valuation
| DGX | FRNM | |
|---|---|---|
| P/E Ratio | 24.65 | — |
| Price / Book | 3.29 | — |
| Price / Sales | 2.23 | — |
DGX and FRNM split the valuation factors evenly.
Profitability
| DGX | FRNM | |
|---|---|---|
| Net Margin | 9.63% | — |
| Return on Equity | 14.23% | — |
DGX and FRNM split the profitability factors evenly.
Dividend
| DGX | FRNM | |
|---|---|---|
| Dividend Yield | 1.48% | — |
| Payout Ratio | 36.52 | — |
DGX and FRNM split the dividend factors evenly.
Risk & Sentiment
| DGX | FRNM | |
|---|---|---|
| Short Interest | 4.76% | 0.41% |
FRNM leads on 1 of 1 risk & sentiment factors.
Dig deeper: DGX overview, DGX financials, FRNM overview, FRNM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.